- Johnson & Johnson (JNJ, Financial) schedules an investor conference call on July 16th to discuss Q2 results.
- CEO Joaquin Duato and CFO Joseph J. Wolk will host the call, with participation from the executive team.
- The call will be available via webcast and phone, with a replay accessible until July 30th.
Johnson & Johnson (JNJ) announced that it will host an investor conference call on Wednesday, July 16th, at 8:30 a.m. Eastern Time to discuss its second-quarter financial results. The call will be led by Chairman and CEO Joaquin Duato, Executive Vice President and CFO Joseph J. Wolk, and Vice President of Investor Relations Darren Snellgrove, along with additional members of the executive team participating in the Q&A session.
The conference call will be accessible through a live webcast found on the company's investor relations website at www.investor.jnj.com. Investors and analysts wishing to participate in the Q&A segment can dial in using the U.S. phone number 877-869-3847 or 201-689-8261 for international callers. A replay of the call will be available approximately three hours post-conference and will be accessible until 12:00 a.m. on July 30th. U.S. participants can access the replay by dialing 877-660-6853, while participants outside the U.S. can use 201-612-7415, with the replay conference ID number being 13754017.
For those interested in more details on Johnson & Johnson’s planned earnings webcasts and conference calls, they can visit the company's investor relations website. The third-quarter conference call is tentatively scheduled for Tuesday, October 14th, 2025.
As a leader in healthcare innovation, Johnson & Johnson continues to focus on advancing healthcare solutions across various fields through innovative approaches and strategic decisions. The company is based in New Brunswick, New Jersey, and is a major player in the pharmaceutical preparations sector, boasting a market cap of $366.90 billion.
